(en) Iwasaki A, Medzhitov R. (2015). Control of adaptive immunity by the innate immune system. Nature Immunology16: 343–353. ISSN: 1529-2908. DOI: 10.1038/ni.3123.
(en) Loker ES, Adema C, Zhang S, Kepler TB (2004). Invertebrate immune systems – not homogeneous, not simple, not well understood. Immunological Reviews198 (1): 10–24. DOI: 10.1111/j.0105-2896.2004.0117.x.
(en) Verhage A, van Wees SC, Pieterse CMJ. (2010). Plant Immunity: It’s the Hormones Talking, But What Do They Say?. Plant Physiology154 (2): 536–540. DOI: 10.1104/pp.110.161570.
(en) Varadé J, Magadán S, González-Fernández A. (2021). Human immunology and immunotherapy: main achievements and challenges. Cellular & Molecular Immunology18: 805–828. DOI: 10.1038/s41423-020-00530-6.
(en) Corthay, A. (2014). Does the immune system naturally protect against cancer?. Frontiers in Immunology5: 197. DOI: 10.3389/fimmu.2014.00197.
(en) Kuziel GA, Rakoff-Nahoum S. (2022). The gut microbiome. Current Biology32 (6): R257-R264. DOI: 10.1016/j.cub.2022.02.023.
(en) Abt MC, Pamer EG. (2014). Commensal bacteria mediated defenses against pathogens. Current Opinion in Immunology29: 16-22. DOI: 10.1016/j.coi.2014.03.003.
(en) Britten RA, Young VB. (2012). Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends in Microbiology20 (7): 313-319. DOI: 10.1016/j.tim.2012.04.001.
(en) Li D, Wu M. (2021). Pattern recognition receptors in health and diseases. Signal Transduction and Targeted Therapy6 (291). DOI: 10.1038/s41392-021-00687-0.
(en) Kanneganti TD, Lamkanfi M, Núñez G. (2007). Intracellular NOD-like Receptors in Host Defense and Disease. Immunity27 (4): 549-559. DOI: 10.1016/j.immuni.2007.10.002.
(en) Sidiq T, Yoshihama S, Downs I, Kobayashi KS. (2016). Nod2: A Critical Regulator of Ileal Microbiota and Crohn’s Disease. Frontiers in immunology7 (367). DOI: 10.3389/fimmu.2016.00367.
(en) Rehwinkel J, Gack M. (2021). RIG-I-like receptors: their regulation and roles in RNA sensing. Nature Reviews Immunology20: 537–551. DOI: 10.1038/s41577-020-0288-3.
(en) Cardamone C, Parente R, Feo G, Triggiani M. (2016). Mast cells as effector cells of innate immunity and regulators of adaptive immunity. Immunology Letters: 10–14. DOI: 10.1016/j.imlet.2016.07.003.
(en) Huang L, Appleton JA. (2016). Eosinophils in Helminth Infection: Defenders and Dupes. Trends in Parasitology: 798–807. PMID27262918. DOI: 10.1016/j.pt.2016.05.004.
(en) Vivier, E, Tomasello, E, Baratin, M, Walzer, T, Ugolini, S (2008). Functions of natural killer cells. Nature Immunology: 503–510. DOI: 10.1038/ni1582.
(en) Sadik CD, Kim ND, Luster AD. (2011). Neutrophils cascading their way to inflammation. Trends in Immunology: 452–460. DOI: 10.1016/j.it.2011.06.008.
(en) Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. (2015). Complement system part I – molecular mechanisms of activation and regulation. Frontiers in immunology6 (262). DOI: 10.3389/fimmu.2015.00262.
(en) Daha, M. (2010). Role of complement in innate immunity and infections. Critical Reviews in Immunology30 (1): 47-52. DOI: 10.1615/critrevimmunol.v30.i1.30.
(en) Romagnani, S. (2006). Immunological tolerance and autoimmunity. Internal and Emergency Medicine1 (3): 187-96. DOI: 10.1007/BF02934736.
(en) Sakaguchi S, Yamaguchi T, Nomura T, Ono M. (2008). Regulatory T Cells and Immune Tolerance. Cell133 (5): 775-787. PMID18510923. DOI: 10.1016/j.cell.2008.05.009.
(en) Knip M, Siljander H. (2008). Autoimmune mechanisms in type 1 diabetes. Autoimmunity Reviews7 (7): 550-557. DOI: 10.1016/j.autrev.2008.04.008.
(en) Andersen MH, Schrama D, Straten P, Becker JC. (2006). Cytotoxic T Cells. Journal of Investigative Dermatology: 32–41. DOI: 10.1038/sj.jid.5700001.
(en) Guthmiller J, Utset HA, Wilson PC. (2021). B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat. Viruses13 (6): 965. DOI: 10.3390/v13060965.
(en) Bouman A, Heinemann MJ, Faas MM. (2005). Sex hormones and the immune response in humans. Human Reproduction Update: 411–423. DOI: 10.1093/humupd/dmi008.
(en) Chakraborty B, Byemerwa J, Krebs T, Lim F, Chang C. (2022). Estrogen Receptor Signaling in the Immune System. Endocrine Reviews. DOI: 10.1210/endrev/bnac017.
(en) Trigunaite A, Dimo J, Jørgensen TN. (2015). Suppressive effects of androgens on the immune system. Cellular Immunology: 87–94. DOI: 10.1016/j.cellimm.2015.02.004.
(en) Besedovsky L, Lange T, Haack M. (2019). The Sleep-Immune Crosstalk in Health and Disease. Physiological Reviews: 1325–1380. PMID30920354. DOI: 10.1152/physrev.00010.2018.
(en) Chapel H, Prevot J, Gaspar HB, Español T, Bonilla FA. (2014). Primary Immune Deficiencies – Principles of Care. Frontiers in Immunology. PMID25566243. DOI: 10.3389/fimmu.2014.00627.
(en) Cirillo E, Giardino G, Gallo V. (2015). Severe combined immunodeficiency-an update: Severe combined immunodeficiencies. Annals of the New York Academy of Sciences: 90–106. DOI: 10.1111/nyas.12849.
(en) Garn H, Renz H. (2007). Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology: 441–452. DOI: 10.1016/j.imbio.2007.03.006.
(en) Garn H, Potaczek DP, Pfefferle PI. (2021). The Hygiene Hypothesis and New Perspectives—Current Challenges Meeting an Old Postulate. Frontiers in Immunology. PMID33815389. DOI: 10.3389/fimmu.2021.637087.
(en) Allison TL (2016). Immunosuppressive Therapy in Transplantation. Nursing Clinics of North America: 107–120. DOI: 10.1016/j.cnur.2015.10.008.
(en) Greenwood, B. (2014). The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci369 (1645): 20130433. DOI: 10.1098/rstb.2013.0433.
(en) Andre FE, Booy R, Bock HL, Clemens J. (2017). Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ86 (2): 140–146. DOI: 10.2471/BLT.07.040089.
(en) Anderson RP, Jabri B. (2013). Vaccine against autoimmune disease: antigen-specific immunotherapy. Current Opinion in Immunology: 410–417. PMID23478068. DOI: 10.1016/j.coi.2013.02.004.
(en) Carlino MS, Larkin J, Long GV. (2021). Immune checkpoint inhibitors in melanoma. The Lancet: 1002–1014. DOI: 10.1016/S0140-6736(21)01206-X.
(en) Onoi K, Chihara Y, Uchino J, Shimamato T, Morimoto Y. (2020). Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review. Journal of Clinical Medicine: 1362. PMID32384677. PMCPMC7290914. DOI: 10.3390/jcm9051362.
(en) Hegde PS, Chen DS. (2020). Top 10 Challenges in Cancer Immunotherapy. Immunity: 17–35. DOI: 10.1016/j.immuni.2019.12.011.
(en) Barrangou R. (2015). The roles of CRISPR–Cas systems in adaptive immunity and beyond. Current Opinion in Immunology: 36–41. DOI: 10.1016/j.coi.2014.12.008.
(en) Leulier F, Lemaitre B. (2008). Toll-like receptors — taking an evolutionary approach. Nature Reviews Genetics: 165–178. DOI: 10.1038/nrg2303.
(en) Jh D. (2015). An Overview of Plant Immunity. Journal of Plant Pathology & Microbiology. DOI: 10.4172/2157-7471.1000322.
(en) Irwin MR. (2019). Sleep and inflammation: partners in sickness and in health. Nature Reviews Immunology 19 (11): 702–715. DOI:10.1038/s41577-019-0190-z.
(en) Andrés A. (2005). Cancer incidence after immunosuppressive treatment following kidney transplantation. Critical Reviews in Oncology/Hematology 56 (1): 71–85. DOI:10.1016/j.critrevonc.2004.11.010.
(en) Besedovsky L, Lange T, Haack M. (2019). The Sleep-Immune Crosstalk in Health and Disease. Physiological Reviews: 1325–1380. PMID30920354. DOI: 10.1152/physrev.00010.2018.
(en) Chapel H, Prevot J, Gaspar HB, Español T, Bonilla FA. (2014). Primary Immune Deficiencies – Principles of Care. Frontiers in Immunology. PMID25566243. DOI: 10.3389/fimmu.2014.00627.
(en) Rosato E, Pisarri S, Salsano F. (2010). Current strategies for the treatment of autoimmune diseases. Journal of Biological Regulators and Homeostatic Agents: 251–259. PMID20846473.
(en) Garn H, Potaczek DP, Pfefferle PI. (2021). The Hygiene Hypothesis and New Perspectives—Current Challenges Meeting an Old Postulate. Frontiers in Immunology. PMID33815389. DOI: 10.3389/fimmu.2021.637087.
(en) Anderson RP, Jabri B. (2013). Vaccine against autoimmune disease: antigen-specific immunotherapy. Current Opinion in Immunology: 410–417. PMID23478068. DOI: 10.1016/j.coi.2013.02.004.
(en) Onoi K, Chihara Y, Uchino J, Shimamato T, Morimoto Y. (2020). Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review. Journal of Clinical Medicine: 1362. PMID32384677. PMCPMC7290914. DOI: 10.3390/jcm9051362.
(en) Iwasaki A, Medzhitov R. (2015). Control of adaptive immunity by the innate immune system. Nature Immunology16: 343–353. ISSN: 1529-2908. DOI: 10.1038/ni.3123.